|
Global Medical Nonwoven Disposables Market
To Reach $12
Billion By 2010
As per the report titled "Medical Nonwoven Disposables: A Global Strategic
Business Report" published by Global Industry Analysts, Inc., Nonwoven
disposables are rapidly making inroads into the medical sector, principally
driven by growing consumer awareness against spread of infectious diseases such
as AIDS and Hepatitis.
The United States is the largest medical nonwovens market in the world and is
projected to exceed $3.4 billion by the year 2010, as stated by Global Industry
Analysts, Inc. With the volume of sophisticated hi-tech surgical intervention
growing rapidly, Europe is projected to experience high growth in medical
nonwovens sector in the coming years. Alternatively, Asia-Pacific offers massive
potential in the long run largely driven by some of the fastest growing global
economies, including China and India.
About 3.3 billion square yards of nonwoven material is used in medical and
surgical applications in North America alone. This indicates the potential of
the market lying ahead and opens up newer revenues for the producers. Among
product segments, surgical nonwoven products market is the largest and the
fastest growing segment and is projected to cross $5.0 billion by the year 2010.
Key players dominating the global medical nonwoven disposables market include
Ahlstrom Corporation, Asahi Kasei Corporation, Attends Healthcare Products,
Buckeye Technologies, Covidien, DUPONT, Fiberweb Plc, Freudenberg Nonwovens,
Hogy Medical, Kao Corporation, Kimberly-Clark Corporation, Medline Industries,
Molnlycke Health Care, Nissan Medical Industries, Polymer Group, Precision
Fabrics Group, SCA Hygiene Products, THE HARTMANN GROUP, and UniCharm Corp.
Reference : Healthcare Purchasing News, May, 2008,
http://findarticles.com/p/articles/mi_m0BPC/is_5_32/ai_n25402377
German Firm Invests Rs 110
Cr In India
Germany-based medical device manufacturer B
Braun has earmarked Rs 110 crore (16 million euros) budget for expanding its
operations in India and is targeting a revenue of around Rs 250 crore by
2010.
"We have invested eight million euros (Rs
55 crores) for setting up a manufacturing plant in Chennai and will pump in
another eight million euros in expanding its capacity in the next two years," B
Braun Vascular System Senior Vice-President Gerd Wacker told PTI.
The company has formed a subsidiary 'B
Braun Medical India Pvt Ltd' to look after its business in India.
It has got the approval of Drug Controller
General of India (DCGI) for introducing around 12 medical devices across
different therapeutic areas and is also waiting for DCGI nod to introduce
another five products in the country.
Apart from hospital care, the company is
operating in India in anasthetics and Surgical instruments.
B Braun has set up a manufacturing unit in
Chennai for manufacturing cardiovascular equipments. From this centre the
company exports devices to other countries, too. Besides this, the company
is also initiating a phase IV clinical trial for its medical device 'drug
eluting balloons' used in the treatment of heart arteries and has plans to
launch it in the next year.It also announced the launch of its next generation
device 'drug eluting stent' (DES) used for the treatment of defected
coronaries.
"In 2008, we are expecting a revenue of Rs 160
crore and by 2010, when all our projects would start contributing to our
revenues, it should cross Rs 250 crore," B.Braun Medical India Business Unit
Manager Vascular System Indranil Mukherji said.
Reference
http://www.business-standard.com/common/
storypage_c_online.php?leftnm=10&bKeyFlag=IN&autono=41759 |
